R. Brown

发表

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.

M. Baccarani, F. Mandelli, P. Cony-Makhoul, 2002, The New England journal of medicine.

Cytokines in Allogeneic Stem Cell Mobilization

R. Vij, J. Dipersio, R. Brown, 2003 .

Effect of melphalan 140 mg/m2 vs 200 mg/m2 on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation—a single center experience

M. Norkin, J. Wingard, Myron N. Chang, 2016, Clinical transplantation.

single-exposure total body irradiation and cyclophosphamide bone marrow transplants who underwent conditioning with low-dose, Chimerism and clinical outcomes of 110 recipients of unrelated donor

R. Vij, J. Dipersio, C. Hallemeier, 2013 .

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide.

R. Vij, J. Dipersio, C. Hallemeier, 2005, Blood.

Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.

R. Vij, J. Dipersio, C. Hallemeier, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Two novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndrome

Marilyn M. Li, Y. Li, R. Hromas, 2015, Leukemia research reports.

A new model to predict remission status in AML patients based on day 14 bone marrow biopsy.

M. Norkin, Y. Li, J. Wingard, 2016, Leukemia research.

Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia.

J. Dipersio, M. Sznol, H. Kantarjian, 2003, Leukemia research.

Dietary intake and Diet Quality of Hematopoietic Stem Cell Transplant Survivors.

J. Wingard, W. May, D. Kelly, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation

G. Herzig, V. Silva, R. Brown, 1991, Journal of clinical apheresis.

Recent advances in allogeneic hematopoietic stem-cell transplantation.

R. Vij, J. Dipersio, S. Devine, 2003, The Journal of laboratory and clinical medicine.

Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.

J. Wingard, C. Cogle, Jack W. Hsu, 2010, Clinical advances in hematology & oncology : H&O.

Chromosomally integrated human herpesvirus‐6 in transplant recipients

R. Razonable, R. Brown, S.‐O. Lee, 2012, Transplant infectious disease : an official journal of the Transplantation Society.

High-Dose Weekly Intravenous Immunoglobulin to Prevent Infections in Patients Undergoing Autologous Bone Marrow Transplantation or Severe Myelosuppressive Therapy: A Study of the American Bone Marrow Transplant Group

R. Collins, J. Fay, J. Greer, 1993, Annals of Internal Medicine.

Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.

D. Scheinberg, R. Stone, M. Kalaycio, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.